These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26717801)

  • 1. Canakinumab for the Patient With Difficult-to-Treat Gouty Arthritis: Review of the Clinical Evidence.
    Bardin T
    Joint Bone Spine; 2015 Oct; 82 Suppl 1():eS9-16. PubMed ID: 26717801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions.
    Schlesinger N; Alten RE; Bardin T; Schumacher HR; Bloch M; Gimona A; Krammer G; Murphy V; Richard D; So AK
    Ann Rheum Dis; 2012 Nov; 71(11):1839-48. PubMed ID: 22586173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Canakinumab: a guide to its use in acute gouty arthritis flares.
    Lyseng-Williamson KA
    BioDrugs; 2013 Aug; 27(4):401-6. PubMed ID: 23649936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Way Forward: Practical Clinical Considerations for the Use of Canakinumab in Patients With Difficult-to-Treat Gouty Arthritis.
    Bardin T; van de Laar MA
    Joint Bone Spine; 2015 Oct; 82 Suppl 1():eS30-2. PubMed ID: 26717800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: Results of a multicenter, phase II, dose-ranging study.
    So A; De Meulemeester M; Pikhlak A; Yücel AE; Richard D; Murphy V; Arulmani U; Sallstig P; Schlesinger N
    Arthritis Rheum; 2010 Oct; 62(10):3064-76. PubMed ID: 20533546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study.
    Schlesinger N; Mysler E; Lin HY; De Meulemeester M; Rovensky J; Arulmani U; Balfour A; Krammer G; Sallstig P; So A
    Ann Rheum Dis; 2011 Jul; 70(7):1264-71. PubMed ID: 21540198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canakinumab relieves symptoms of acute flares and improves health-related quality of life in patients with difficult-to-treat Gouty Arthritis by suppressing inflammation: results of a randomized, dose-ranging study.
    Schlesinger N; De Meulemeester M; Pikhlak A; Yücel AE; Richard D; Murphy V; Arulmani U; Sallstig P; So A
    Arthritis Res Ther; 2011 Mar; 13(2):R53. PubMed ID: 21439048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying Patient Candidates for IL-1 Inhibition: Lessons From Real-World Cases.
    Avram A; Duarte C; Santos MJ; Papagoras C; Ritis K; Scarpioni R; Schmidt WA; Skendros P
    Joint Bone Spine; 2015 Oct; 82 Suppl 1():eS17-29. PubMed ID: 26717798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chronic gouty arthritis: it is not just about urate-lowering therapy.
    Schlesinger N
    Semin Arthritis Rheum; 2012 Oct; 42(2):155-65. PubMed ID: 22542277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Canakinumab vs. triamcinolone acetonide according to multiple gouty arthritis-related health outcomes measures.
    Hirsch JD; Gnanasakthy A; Lale R; Choi K; Sarkin AJ
    Int J Clin Pract; 2014 Dec; 68(12):1503-7. PubMed ID: 25298264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis.
    Cronstein BN; Sunkureddi P
    J Clin Rheumatol; 2013 Jan; 19(1):19-29. PubMed ID: 23319019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of acute gout: a systematic review.
    Khanna PP; Gladue HS; Singh MK; FitzGerald JD; Bae S; Prakash S; Kaldas M; Gogia M; Berrocal V; Townsend W; Terkeltaub R; Khanna D
    Semin Arthritis Rheum; 2014 Aug; 44(1):31-8. PubMed ID: 24650777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difficult-to-treat gout flares: eligibility for interleukin-1 inhibition in private practice is uncommon according to current EMA approval.
    Pascart T; Norberciak L; Ea HK; Graf S; Guggenbuhl P; Lioté F
    Rheumatology (Oxford); 2019 Dec; 58(12):2181-2187. PubMed ID: 31177284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current concepts in the treatment of gouty arthritis.
    Fang ZH; Waizy H
    Orthop Surg; 2013 Feb; 5(1):6-12. PubMed ID: 23420740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canakinumab in gout.
    Schlesinger N
    Expert Opin Biol Ther; 2012 Sep; 12(9):1265-75. PubMed ID: 22784099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of acute and chronic gouty arthritis: present state-of-the-art.
    Schlesinger N
    Drugs; 2004; 64(21):2399-416. PubMed ID: 15481999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foreword.
    Bardin T; van de Laar MA
    Joint Bone Spine; 2015 Oct; 82 Suppl 1():eS1. PubMed ID: 26717797
    [No Abstract]   [Full Text] [Related]  

  • 18. Interleukin-1 as a therapeutic target in gout.
    Dumusc A; So A
    Curr Opin Rheumatol; 2015 Mar; 27(2):156-63. PubMed ID: 25633244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy and safety of treatments for acute gout: results from a series of systematic literature reviews including Cochrane reviews on intraarticular glucocorticoids, colchicine, nonsteroidal antiinflammatory drugs, and interleukin-1 inhibitors.
    Wechalekar MD; Vinik O; Moi JH; Sivera F; van Echteld IA; van Durme C; Falzon L; Bombardier C; Carmona L; Aletaha D; Landewé RB; van der Heijde DM; Buchbinder R
    J Rheumatol Suppl; 2014 Sep; 92():15-25. PubMed ID: 25180124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic properties of canakinumab in patients with gouty arthritis.
    Chakraborty A; Van LM; Skerjanec A; Floch D; Klein UR; Krammer G; Sunkara G; Howard D
    J Clin Pharmacol; 2013 Dec; 53(12):1240-51. PubMed ID: 24122883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.